Schering-Plough 2% Gyne-Lotrimin 3 Cream Will Be Launched In February
This article was originally published in The Tan Sheet
Executive Summary
A new dosage form of Schering-Plough's vaginal yeast infection treatment Gyne-Lotrimin 3 with a 2% dose of the active ingredient clotrimazole will be introduced by the company in February. Schering plans no major advertising but will undertake FSIs.